Drug Trial Radar · NCT06615557
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
238
Actual
Start
Sep 16, 2024
Primary completion
Apr 21, 2026
Study completion Jul 14, 2026
Sponsor
- Lead sponsor
- VistaGen Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve symptoms of acute anxiety in adult subjects ages 18 through 65 with Social Anxiety Disorder induced by a public speaking challenge (PSC) in a clinical setting. In addition, safety and tolerability of i.n. administration of 3.2 µg of fasedienol, as-needed, up to 6 times per day for up to 12 months, will be assessed in those subjects who complete PALISADE-4 and choose to enter the distinct open-label extension phase of the study.
Conditions
- Social Anxiety Disorder (SAD)
Interventions
Fasedienol Nasal SprayDrug
Nasal spray delivered 20 minutes before the PSC
Placebo Nasal SprayDrug
Nasal spray delivered 20 minutes before the PSC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjective Units of Distress Scale (SUDS)Time frame: 7 days (Visit 2 to Visit 3)
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Vistagen Clinical Site
Phoenix, Arizona
Vistagen Clinical Site
Little Rock, Arkansas
Vistagen Clinical Site
Bellflower, California
Vistagen Clinical Site
Oceanside, California
Vistagen Clinical Site
Orange, California
Vistagen Clinical Site
Redlands, California
Vistagen Clinical Site
Torrance, California
Vistagen Clinical Site
Denver, Colorado
Vistagen Clinical Site
Tampa, Florida
Vistagen Clinical Site
Decatur, Georgia
Vistagen Clinical Site
Chicago, Illinois
Vistagen Clinical Site
Naperville, Illinois
Vistagen Clinical Site
Boston, Massachusetts
Vistagen Clinical Site
Bloomfield Township, Michigan
Vistagen Clinical Site
Flowood, Mississippi
Vistagen Clinical Site
Las Vegas, Nevada
Vistagen Clinical Site
Las Vegas, Nevada
Vistagen Clinical Site
Albuquerque, New Mexico
Vistagen Clinical Site
New York, New York
Vistagen Clinical Site
Cincinnati, Ohio
Vistagen Clinical Site
Austin, Texas
Vistagen Clinical Site
Austin, Texas
Vistagen Clinical Site
Dallas, Texas
Vistagen Clinical Site
Houston, Texas
Vistagen Clinical Site
San Antonio, Texas
Vistagen Clinical Site
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.